Charles F. Schwartz

High-Risk Aortic Valve Replacement: Are the Outcomes as Bad as Predicted?

Eugene A. Grossi, Charles F. Schwartz, Pey-Jen Yu et al. · The Annals of Thoracic Surgery · 2007 · 217 citations · Full text

Heart Failure, Cardiovascular Disease, Aortic Diseases +14

Rat liver insulin mediator which stimulates pyruvate dehydrogenase phosphatase contains galactosamine and D-chiroinositol

Joseph Larner, Laura C. Huang, Charles F. Schwartz et al. · Biochemical and Biophysical Research Communications · 1988 · 204 citations

Metabolic Syndrome, Energy Metabolism, Pyruvate Dehydrogenase Phosphatase +12

A Decade of Minimally Invasive Mitral Repair: Long-Term Outcomes

Aubrey C. Galloway, Charles F. Schwartz, Greg H. Ribakove et al. · The Annals of Thoracic Surgery · 2009 · 137 citations

Minimally Invasive Procedure, Operative Treatment, Reconstructive Surgery +5

Outcomes of the RESTOR-MV Trial (Randomized Evaluation of a Surgical Treatment for Off-Pump Repair of the Mitral Valve)

Eugene A. Grossi, Nirav Patel, Y. Joseph Woo et al. · Journal of the American College of Cardiology · 2010 · 126 citations

Cardiothoracic Surgery, Outcomes Research, Mitral Valve +9

Off-Pump Coronary Artery Bypass Grafting Reduces Mortality and Stroke in Patients With Atheromatous Aortas: A Case Control Study

Ram Sharony, Costas Bizekis, Marc S. Kanchuger et al. · Circulation · 2003 · 117 citations